Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:1020 (19 May), doi:10.1136/bmj.39212.685637.3A
blockers| The first 100% of the full text of this article appears below. |
The data presented in table 1 of Ong's review leave considerable uncertainty about whether atenolol is better or worse than other
blockers.1 The confidence intervals for the results on other
blockers are wide (as fewer patients have been studied), and the test for interaction shows that the relative risk for atenolol, compared with other
blockers, for stroke is 1.05 (95% confidence interval 0.26 to 4.17), for myocardial infarction 1.22 (0.91 to 1.63), and for total mortality 1.21 (0.95 to 1.14). All of these confidence intervals include the possibility of no difference, and for stroke the results are compatible with atenolol being four times better or four times worse than other
blockers. It is very misleading to draw conclusions based on whether significance is achieved with either treatment alone.2
Christopher J Cates, general practitioner
Manor View Practice, Bushey WD23 2NN
chris.cates@nhs.net
blockers in hypertension and cardiovascular disease. BMJ 2007;334:946-9. (5 May.)
blockers in hypertension and cardiovascular disease